Gabapentin Capsule
Product Images NDC 76420-869

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76420-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg (100mg Label)

Labels for Gabapentin Capsules, USP 100 mg, supplied by Enovachem Pharmaceuticals and relabeled by Asclemed USA, Inc. The labels show multiple NDC codes including 76420-868-12, 76420-868-24, 76420-868-30, 76420-868-60, 76420-868-90, 76420-868-01, 76420-868-05, and 76420-868-00. Package quantities range from 30 to 1000 capsules. Labels include manufacturer and batch information, dosage form as capsules, and caution about prescription dispensing and storage.*

FDA Label Image

300 mg (300mg Label)

Labels for Gabapentin Capsules USP 300 mg by Asclemed USA, Inc., showing multiple package sizes including quantities of 30, 60, 90, 100, 120, 240, and 500 capsules. Labels display NDC codes, barcode, packaging details, manufacturer information (Camber Pharmaceuticals, Inc.), and a caution statement about prescription dispensing. Packaged and relabeled by Enovachem Pharmaceuticals, Torrance, CA.*

FDA Label Image

400 mg (400mg Label)

Labels for Gabapentin Capsules USP 400 mg from Enovachem Pharmaceuticals, showing various package quantities including 30, 60, 90, 100, 120, 240, and 500 capsules. The labels indicate the product is manufactured for Camber Pharmaceuticals, Inc., with an orange opaque capsule body and cap. Each label includes the NDC number, lot, expiration date, and storage instructions.*

FDA Label Image

Equation (Equation)

A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and sex adjustment for female patients. It is a text panel showing the equation used in clinical pharmacology contexts.*

FDA Label Image

Fig 1 (Fig 1)

A line chart titled "Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1" comparing mean pain scores over 8 weeks. It shows two lines: one for placebo starting around 7 and remaining fairly constant, and another for gabapentin 3600 mg/day, which decreases from about 6 to about 4 over the weeks. The x-axis represents weeks, and the y-axis shows mean pain score from 0 to 10. Periods for "Week Dose Titration" and "Week Fixed Dose" are indicated on the graph.*

FDA Label Image

Fig 2 (Fig 2)

A line graph depicting weekly mean pain scores over seven weeks for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis shows mean pain scores ranging from 0 to 10. Data compare scores during a 3-week dose titration period and a 4-week fixed dose period.*

FDA Label Image

Fig 3 (Fig 3)

A bar chart titled 'Proportion of Responders (patients with 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing response rates in three treatment groups versus placebo (PBO) across two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600. Study 2 shows 14% responders for placebo, 32% for GBP 1800, and 34% for GBP 2400. Statistical significance markers indicate p-values less than 0.01 and 0.001 for certain groups.*

FDA Label Image

Fig 4 (Fig 4)

A scatter plot chart depicting responder rate differences in patients receiving gabapentin versus placebo across various daily doses (600 mg, 900 mg, 1200 mg, 1800 mg). The chart compares three studies labeled as Study a, Study b, and Study c, with differences expressed as percentages on the vertical axis and daily dose in mg on the horizontal axis.*

FDA Label Image

Structure (Struct)

Chemical structure diagram of gabapentin showing a cyclohexane ring bonded to an amine group (CH2NH2) and a carboxylic acid group (CH2CO2H).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.